<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">12682475</PMID>
<DateCompleted>
<Year>2003</Year>
<Month>05</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0090-3493</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2003</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Critical care medicine</Title>
<ISOAbbreviation>Crit. Care Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Microalbuminuria in critically ill medical patients: prevalence, predictors, and prognostic significance.</ArticleTitle>
<Pagination>
<MedlinePgn>1075-81</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To ascertain the prevalence, predictors, and prognostic significance of microalbuminuria in critically ill patients.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective cohort study.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Medical intensive care unit of a community teaching hospital.</AbstractText>
<AbstractText Label="PATIENTS" NlmCategory="METHODS">Admitted critically ill patients.</AbstractText>
<AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">We measured serial spot urine albumin-creatinine ratios in 104 critically ill patients, with a median age of 64.5 yrs and median Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores of 20.5 and 5.0, respectively. Sixty-nine percent of the patients had microalbuminuria or clinical proteinuria and 43.3% had an albumin-creatinine ratio &gt;/=100 mg/g at admission. The acuity of illness, being non-White, and having diabetes mellitus were independent predictors of albumin-creatinine ratio &gt;/=100 mg/g. The overall mortality rate was 26.9% (28/104). Patients with an albumin-creatinine ratio &gt;/=100 mg/g were 2.7 times as likely to die compared with those with an albumin-creatinine ratio &lt;100 mg/g, even after simultaneous adjustments for age, and APACHE II and SOFA scores (odds ratio, 2.7; 95% confidence interval, 1.1-7.2, p =.04). The association of albumin-creatinine ratio &gt;/=100 mg/g with death was consistent across age, ethnicity, renal function, acuity of illness, and comorbid conditions. Among survivors, patients with an albumin-creatinine ratio &gt;/=100 mg/g stayed approximately 5 days longer in the hospital (p =.0007). Overall, the albumin-creatinine ratio shared similar predictive characteristics with APACHE II and SOFA scores.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study confirms a high prevalence of microalbuminuria in critically ill patients and suggests that an albumin-creatinine ratio &gt;/=100 mg/g is an independent predictor of mortality and hospital stay.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Thorevska</LastName>
<ForeName>Natalya</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Departments of Medicine, Bridgeport Hospital, Yale-New Haven Health, Bridgeport, CT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sabahi</LastName>
<ForeName>Ramin</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Upadya</LastName>
<ForeName>Anupama</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Manthous</LastName>
<ForeName>Constantine</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Amoateng-Adjepong</LastName>
<ForeName>Yaw</ForeName>
<Initials>Y</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Crit Care Med</MedlineTA>
<NlmUniqueID>0355501</NlmUniqueID>
<ISSNLinking>0090-3493</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>AYI8EX34EU</RegistryNumber>
<NameOfSubstance UI="D003404">Creatinine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018806">APACHE</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D000419">Albuminuria</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003404">Creatinine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000652">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016638">Critical Illness</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000401">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005919">Glomerular Filtration Rate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007902">Length of Stay</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009102">Multiple Organ Failure</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011237">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011507">Proteinuria</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012680">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015996">Survival Rate</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2003</Year>
<Month>4</Month>
<Day>12</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2003</Year>
<Month>5</Month>
<Day>2</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2003</Year>
<Month>4</Month>
<Day>12</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">12682475</ArticleId>
<ArticleId IdType="doi">10.1097/01.CCM.0000059316.90804.0B</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>